Session 3B: Aligning clinical supply and cell therapy for scalable impact
Tracks
Track 3
Wednesday, October 22, 2025 |
4:05 PM - 4:50 PM |
Details
Cell therapies are redefining the future of medicine, offering potentially curative treatments for cancer, autoimmune disorders, and genetic diseases. But their promise comes with unprecedented operational challenges—from complex manufacturing timelines to real-time patient coordination and ultra-cold chain logistics. This panel brings together cross-functional leaders to discuss how alignment is critical for successful clinical trial execution. By combining scientific vision with supply innovation, we will explore strategies to overcome the key challenges in cell therapy trial, particularly in international settings involving multi-site coordination, cross-border transport, and varying regulatory requirements. Special attention will be given to the management of cell therapy products across global locations, including strategies for harmonising site processes and maintaining traceability. Additionally, the panel will highlight best practices for conducting in-use compatibility studies and managing ancillary materials—key, but often overlooked, aspects of cell therapy development.
Speaker
Amel Hadri
Chief Executive Officer & Founder
Inits
Chair
